EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.17.23 | angiotensin I | - |
Homo sapiens | |
3.4.17.23 | DX600 | IC50: 10 nM | Homo sapiens | |
3.4.17.23 | MLN-4760 | i.e. (SS) 2-[(1)-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]ethylamino]-4-methyl-pentanoic acid, IC50: 0.44 nM | Homo sapiens | |
3.4.17.23 | Pro-Phe | IC50: 0.15 mM | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.17.23 | additional information | Homo sapiens | the enzyme is involved in diesease condition including hypertension, diabetes and cardiac function. ACE2 is the SARS virus receptor | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.17.23 | Homo sapiens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.17.23 | angiotensin I + H2O | - |
Homo sapiens | angiotensin-(1-9) + Leu | - |
? | |
3.4.17.23 | angiotensin II + H2O | - |
Homo sapiens | angiotensin-(1-7) + Phe | - |
? | |
3.4.17.23 | angiotensin IV + H2O | - |
Homo sapiens | VYIHP + Phe | - |
? | |
3.4.17.23 | apelin-13 + H2O | - |
Homo sapiens | QRPRLSHKGPMP + Phe | - |
? | |
3.4.17.23 | apelin-36 + H2O | - |
Homo sapiens | ? | - |
? | |
3.4.17.23 | beta-casomorphin + H2O | - |
Homo sapiens | YPFVEP + Ile | - |
? | |
3.4.17.23 | des-Arg9-bradykinin + H2O | - |
Homo sapiens | RPPGFSP + Phe | - |
? | |
3.4.17.23 | dynorphin A(1-13) + H2O | - |
Homo sapiens | YGGFLRRIRPKL + Lys | - |
? | |
3.4.17.23 | ghrelin + H2O | - |
Homo sapiens | ? | - |
? | |
3.4.17.23 | Lys-des-Arg9 bradykinin + H2O | - |
Homo sapiens | KRPPGFSP + Phe | - |
? | |
3.4.17.23 | additional information | the enzyme is involved in diesease condition including hypertension, diabetes and cardiac function. ACE2 is the SARS virus receptor | Homo sapiens | ? | - |
? | |
3.4.17.23 | additional information | no hydrolysis of angiotensin (1-9), angiotensin (1-7), bradikinin, bradykinin(1-7), neurotensin(1-13) | Homo sapiens | ? | - |
? | |
3.4.17.23 | neurotensin(1-11) + H2O | - |
Homo sapiens | pELYENKPRRP + Tyr | - |
? | |
3.4.17.23 | neurotensin(1-8) + H2O | - |
Homo sapiens | pELYENKP + Arg | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.17.23 | ACE2 | - |
Homo sapiens |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.17.23 | 0.0000028 | - |
DX600 | - |
Homo sapiens | |
3.4.17.23 | 0.0022 | - |
angiotensin I | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.4.17.23 | 0.00000044 | - |
i.e. (SS) 2-[(1)-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]ethylamino]-4-methyl-pentanoic acid, IC50: 0.44 nM | Homo sapiens | MLN-4760 | |
3.4.17.23 | 0.00001 | - |
IC50: 10 nM | Homo sapiens | DX600 | |
3.4.17.23 | 0.15 | - |
IC50: 0.15 mM | Homo sapiens | Pro-Phe |